Skip to content
10-K

Annual Report

Q Therapeutics, Inc.

0001193125-15-114403

← back to feed
Filed
Mar 31, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Mar 31, 2015 30.83M sh
Capex FY 2014 · Dec 31, 2014 $8.23K
Capex FY 2014 · Dec 31, 2013 $23.8K
Operating Cash Flow FY 2014 · Dec 31, 2014 −$1.46M
Operating Cash Flow FY 2014 · Dec 31, 2013 −$877.87K
Cash And Equivalents FY 2014 · Dec 31, 2014 $707.01K
Cash And Equivalents FY 2014 · Dec 31, 2013 $142.53K
Cash And Equivalents FY 2014 · Dec 31, 2012 $794.21K
Stockholders Equity FY 2014 · Dec 31, 2014 −$295.85K
Stockholders Equity FY 2014 · Dec 31, 2013 −$3.04M
Stockholders Equity FY 2014 · Dec 31, 2012 $4.99K
Current Liabilities FY 2014 · Dec 31, 2014 $1.04M
Current Liabilities FY 2014 · Dec 31, 2013 $3.3M
Current Assets FY 2014 · Dec 31, 2014 $721.74K
Current Assets FY 2014 · Dec 31, 2013 $221.53K
Total Assets FY 2014 · Dec 31, 2014 $748.31K
Total Assets FY 2014 · Dec 31, 2013 $257.04K
Sga Expense FY 2014 · Dec 31, 2014 $2.1M
Sga Expense FY 2014 · Dec 31, 2013 $1.38M
Rd Expense FY 2014 · Dec 31, 2014 $1.96M
Rd Expense FY 2014 · Dec 31, 2013 $1.83M
Net Income FY 2014 · Dec 31, 2014 −$3.35M
Net Income FY 2014 · Dec 31, 2013 −$3.39M
Operating Income FY 2014 · Dec 31, 2014 −$3.38M
Operating Income FY 2014 · Dec 31, 2013 −$3.19M
Gross Profit FY 2014 · Dec 31, 2014 $679.46K
Gross Profit FY 2014 · Dec 31, 2013 $21.38K
Cost Of Revenue FY 2014 · Dec 31, 2014 $800
Cost Of Revenue FY 2014 · Dec 31, 2013 $4.8K
Revenue FY 2014 · Dec 31, 2014 $680.26K
Revenue FY 2014 · Dec 31, 2013 $26.18K